Accuray reported $116.17M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Trinity Biotech USD 11.07M 3.24M Dec/2025